GENE ONLINE|News &
Opinion
Blog

Cholesterol
Innovent’s PCSK-9 Antibody Meets Primary Endpoints in Two Phase 3 Studies
2022-02-18
Verve Raises $94M in Series B, Aims to Disrupt Cardiology Market with ‘Once-and-Done’ Gene Editing Therapies
2021-01-21
AstraZeneca Sells its Cholesterol Drug to German Pharma
2020-12-03
Regeneron’s Antibody Therapy Reduces LDL Cholesterol in Hypercholesterolemia Patients
2020-11-21
FDA Approval of Cholesterol Lowering Drug, NEXLETOL, A Value-Add to Existing Treatments
2020-02-25
December 22, 1955: German-American Biochemist Thomas Christian Südhof was Born
2017-12-22
LATEST
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
2023-03-24
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
FDA Extends Approval Of Regeneron’s Evkeeza For Inherited High Cholesterol
2023-03-23
Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.
2023-03-23
Scroll to Top